EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg) HCP

Epclusa® (sofosbuvir 400 mg/velpatasvir 100 mg) hcp email format

Verified email-pattern data for Epclusa® (Sofosbuvir 400 Mg/velpatasvir 100 Mg) Hcp is currently limited. You can still use the company insights and contact sections below.
Please see full Prescribing Information for EPCLUSA, including BOXED WARNING, at https://bit.ly/3mw8Klx and at hcp.EPCLUSA.com. To report SUSPECTED ADVERSE REACTIONS, contact Gilead Sciences, Inc. at 1-800-GILEAD-5 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. EPCLUSA, the EPCLUSA Logo, GILEAD, and the GILEAD Logo are trademarks of Gilead Sciences, Inc., or its related companies. ©2024 Gilead Sciences, Inc. All rights reserved. US-EPCP-0484 07/24
Looking for a particular EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg) HCP employee's phone or email?

Epclusa® (Sofosbuvir 400 Mg/velpatasvir 100 Mg) Hcp Questions

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant